Project Grant R43MH138930
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Small Business Innovation Research (SBIR) Phase I project award of $274,998 to Magnify Biosciences Inc. aims to develop an automated "AutoMagnify" device that physically expands biological specimens up to 1,000 times in 3D while preserving spatial and molecular integrity. This advancement will enable conventional light microscopes to achieve nanoscale imaging resolution capabilities...
- This $2.72 million Project Grant award from the National Institute of Neurological Disorders and Stroke under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) supports the development of advanced high-speed imaging sensors and microscopy methods at the Massachusetts Institute of Technology. The award, which commenced August 1, 2025 and concludes July 31, 2028, funds the design and fabrication of novel complementary...
- The University of Minnesota was awarded a $3,972,414 Project Grant from the National Institute of Neurological Disorders and Stroke within the Department of Health and Human Services to develop an electro-optical multiphoton microscope. The microscope will leverage advances in electro-optical beam deflection to enable random-access multiphoton interrogation of neurons and synapses with sub-microsecond access times. This will allow neuroscientists to collect the simultaneous recordings needed...
- The National Institute of Mental Health (NIMH) awarded a $2,490,741 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to President and Fellows of Harvard College (Harvard University) to develop the THERMAL-PLEX method. This fluidic-free, rapid sequential imaging technique enables multiplexed analysis of RNA and protein in brain tissues, providing critical insights into the spatial organization of molecular targets. The 3-year project aims to remove complex and slow...
- The University of Illinois has been awarded a $1,870,822 Project Grant from the National Institute on Aging's Aging Research program (CFDA 93.866) to develop new super-resolution fluorescence microscopy techniques. The goal is to achieve ultra-high resolution imaging of native amyloid-alpha receptors (AMPARs) in brain slices to study synaptic plasticity in both healthy and tauopathy conditions. The research will utilize multi-color imaging and digital image reconstruction methods to isolate...
- The National Institutes of Health (NIH) Office of the Director awarded a $1,271,280 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Allen Institute in Seattle, WA. The award, spanning September 2024 to September 2027, aims to develop two "exa-scale" (extremely high-throughput) tissue readout methods to transform the study of the brain. The first method will enable highly multiplexed molecular mapping of individual proteins across entire brains at the...
- This $1,417,500 Project Grant awarded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) funds the development of "Electrified Cryo-EM", a novel tool that can kinetically trap biological systems in their metastable, non-equilibrium states. The research aims to unravel the structural changes in neurons during an action potential across multiple length scales, from voltage-gated channel proteins to the synaptic junction. Specifically,...
- This NSF Engineering Program award of $605,320 to North Carolina State University (NC State) supports the development of a flexible, FMRI-compatible neural probe with multi-modal sensing and modulation capabilities. The novel probe is designed to advance understanding of neural circuit dynamics and enable closed-loop neuromodulation for treating neurological disorders. Key product elements include: Flexible, multi-shank neural probe fabricated using polymeric materials to enable deep brain...
- This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $994,138 to Modendo Inc., a for-profit company located in Boulder, CO, to develop and validate a prototype ultrathin endomicroscope instrument for high-resolution, minimally invasive optical imaging of the brain in animal neuroscience research. The key innovation is achieving a cross-sectional area more than 10 times smaller than...
- Project Grant Award Summary The National Science Foundation's Division of Biological Infrastructure awarded Georgia TECH Research Corp a Project Grant of $861,467 (Award Date: September 1, 2025; Completion Date: August 31, 2028) to develop and implement Parallel Multifocal Scanning Microscopy (PMS), a super-resolution imaging technique for cellular and tissue analysis. The project delivers a comprehensive research infrastructure innovation encompassing three primary objectives: (1) development...
MULTIPLEX MAGNIFY PROTOCOL AND KIT FOR HIGH PLEX, SUPERRESOLUTION 3D SYNAPTIC IMAGING AND ANALYSIS IN NEUROSCIENCE - PROJECT SUMMARY SYNAPSES ARE INTRICATE STRUCTURES SMALLER THAN 1 MICRON, ENCOMPASSING THOUSANDS OF SUBTYPES, EACH DEFINED BY A UNIQUE COMPOSITION OF FUNCTIONAL PROTEINS. THE ABILITY TO MAP THE 3D ORGANIZATION OF THESE PROTEINS IS KEY FOR COMPREHENDING THE MOLECULAR ANATOMY AND MECHANISMS UNDERLYING BRAIN FUNCTIONS AND DISEASES. CONVENTIONAL OPTICAL MICROSCOPY, LIMITED BY A RESOLUTION OF ~250 NM, FALLS SHORT OF RESOLVING THE COMPLEX SPATIAL ORGANIZATION OF SYNAPTIC PROTEINS. MEANWHILE, ELECTRON MICROSCOPY (EM) AND VARIOUS SUPER- RESOLUTION OPTICAL IMAGING TECHNIQUES LIKE STED AND SMLM ARE HINDERED BY A LACK OF MOLECULAR SPECIFICITY, CHALLENGES IN 3D IMAGING, AND THE LABOR-INTENSIVE, SLOW, AND COSTLY NATURE OF THE OPERATION. THIS GAP IN TECHNOLOGY HAS LEFT SYNAPSE TYPING UNADDRESSED UNTIL THE RECENT DEVELOPMENT OF THE NEXT-GENERATION EXPANSION MICROSCOPY TECHNIQUE, MAGNIFY. MAGNIFY OFFERS AN ~11-FOLD LINEAR EXPANSION OF BIOLOGICAL SPECIMENS IN A SINGLE ROUND, ENSURING EFFICIENT RETENTION OF PROTEINS, NUCLEIC ACIDS, AND LIPIDS. IT IS COMPATIBLE WITH VARIOUS TISSUE TYPES AND FIXATION METHODS WHILE PRESERVING EPITOPES FOR HIGH-PLEX IMAGING. BY REACHING ~15 NM RESOLUTION, MAGNIFY CAN DISCERN ULTRASTRUCTURAL DETAILS SUCH AS CILIA, MITOCHONDRIA CRISTAE, AND SYNAPTIC DENSITIES. WE SEEK TO BUILD THE PROTOTYPE OF THE MULTIPLEX MAGNIFY SAMPLE PREPARATION KITS AS A UNIVERSAL TOOL FOR SYNAPSE TYPING AND BRAIN IMAGING. OUR GOAL IS TO EQUIP NEUROSCIENTISTS WITH THE ABILITY TO PERFORM EM-QUALITY 3D ULTRASTRUCTURAL ANALYSIS, MAPPING AN EXTENSIVE ARRAY OF BIOMOLECULAR MARKERS WITHIN THE INTRICATE SYNAPTIC STRUCTURES IN BRAIN TISSUE AT A FRACTION OF THE COST AND TIME USING ONLY A LIGHT MICROSCOPE. IN OUR PROJECT, WE WILL ENHANCE THE CAPABILITIES OF OUR MAGNIFY TECHNOLOGY IN NEUROSCIENCE RESEARCH THROUGH THE FOLLOWING AIMS: (1) VALIDATE MAGNIFY-COMPATIBLE ANTIBODIES AND A NOVEL DIRECT IMMUNOSTAINING STRATEGY FOR KEY SYNAPTIC MARKERS TO GENERATE A LIBRARY OF LABELS FOR NEUROSCIENCE RESEARCHERS; (2) DEVELOP A MOUNTING STRATEGY FOR MULTIPLEX IMMUNOFLUORESCENCE IMAGING OF SYNAPSES TO ENSURE HIGH-FIDELITY IMAGES THROUGH AT LEAST 10 ROUNDS OF IMAGING; AND (3) DEVELOP A MULTIPLEX MAGNIFY KIT PROTOTYPE FOR EASY ADOPTION FOR NEUROSCIENCE RESEARCH. UPON SUCCESSFUL COMPLETION, MAGNIFY BIOSCIENCES WILL PRODUCE MULTIPLEX MAGNIFY SAMPLE PREPARATION KITS FOR NEUROSCIENTISTS CONDUCTING SIMULTANEOUS 3D ULTRASTRUCTURAL ANALYSIS, NEURONAL TRACING, SYNAPSE TYPING, ETC., IN BRAIN TISSUE. OUR WORK WILL PREPARE FOR A PHASE II GRANT TO INCREASE MULTIPLEXING WITH BARCODED OLIGO-CONJUGATED FLEXIBLE BINDERS AND A LARGER ANTIBODY PANEL AND TO ADVANCE THE PROTOTYPE WITH AN AUTOMATED AUTO-MAGNIFY DEVICE FOR AUTONOMOUS, MULTIPLEXED NANOSCALE IMAGING, ENHANCING SUPER-RESOLUTION IMAGING ACCESSIBILITY FOR ADVANCED BRAIN RESEARCH.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $451.1k | 8/28/25 | ||
| Not listed | $457.0k | 8/1/24 |